Cargando…
Pulmonary Complications Associated with HSCT
While outcomes for patients who undergo allogeneic hematopoietic stem cell transplantation (HSCT) have improved over the past 10–20 years, pulmonary complications after allogeneic HSCT remain a leading cause of morbidity and mortality. Overall, 25–50% of pediatric HSCT patients will develop pulmonar...
Autores principales: | Kapadia, Malika, Shapiro, Terry Wikle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123319/ http://dx.doi.org/10.1007/978-3-319-63146-2_21 |
Ejemplares similares
-
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
por: Reis, Monica, et al.
Publicado: (2016) -
Pathophysiology of GvHD and Other HSCT-Related Major Complications
por: Ghimire, Sakhila, et al.
Publicado: (2017) -
Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT
por: Santos, Paulo Sérgio da Silva, et al.
Publicado: (2023) -
Dental consensus on HSCT – Part II: dental Care during HSCT
por: Gobbi, Marcella Ferreira, et al.
Publicado: (2023) -
Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
por: Bis, Gabriela, et al.
Publicado: (2020)